Arch Biopartners Inc. (TSXV:ARCH)

Arch Biopartners Revenue

Arch Biopartners had revenue of 117.87K CAD in the quarter ending December 31, 2024, a decrease of -60.47%. This brings the company's revenue in the last twelve months to 1.94M, up 5.12% year-over-year. In the fiscal year ending September 30, 2024, Arch Biopartners had annual revenue of 2.12M with 6.97% growth.

• Revenue (ttm): 1.94M
• Revenue Growth: +5.12%
• P/S Ratio: n/a
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 112.91M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	2.12M	138.21K	6.97%
Sep 30, 2023	1.98M	1.02M	105.63%
Sep 30, 2022	964.68K	-2.92M	-75.18%
Sep 30, 2021	3.89M	3.82M	5,625.22%
Sep 30, 2020	67.89K	-25.99K	-27.69%